BRPI0915126A2 - derivados de (piperazinil em ponte) -1 alcanona e a respectiva utilização como inibidores de p75 - Google Patents
derivados de (piperazinil em ponte) -1 alcanona e a respectiva utilização como inibidores de p75Info
- Publication number
- BRPI0915126A2 BRPI0915126A2 BRPI0915126A BRPI0915126A BRPI0915126A2 BR PI0915126 A2 BRPI0915126 A2 BR PI0915126A2 BR PI0915126 A BRPI0915126 A BR PI0915126A BR PI0915126 A BRPI0915126 A BR PI0915126A BR PI0915126 A2 BRPI0915126 A2 BR PI0915126A2
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitors
- alkanone derivatives
- bridged piperazinyl
- piperazinyl
- bridged
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0803299A FR2932482B1 (fr) | 2008-06-13 | 2008-06-13 | Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75 |
| FR0803299 | 2008-06-13 | ||
| PCT/FR2009/051118 WO2009150388A1 (fr) | 2008-06-13 | 2009-06-12 | NOUVEAUX DERIVES DE (PIPERAZINYL PONTE)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0915126A2 true BRPI0915126A2 (pt) | 2016-02-16 |
| BRPI0915126B1 BRPI0915126B1 (pt) | 2019-09-24 |
| BRPI0915126B8 BRPI0915126B8 (pt) | 2021-05-25 |
Family
ID=40305395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0915126A BRPI0915126B8 (pt) | 2008-06-13 | 2009-06-12 | derivados de (piperazinil em ponte) -1 alcanona como inibidores de p75, seu processo de preparo e composição farmacêutica |
Country Status (39)
| Country | Link |
|---|---|
| US (2) | US8193190B2 (pt) |
| EP (1) | EP2297148B8 (pt) |
| JP (1) | JP5476373B2 (pt) |
| KR (1) | KR101642526B1 (pt) |
| CN (1) | CN102124006B (pt) |
| AR (1) | AR072103A1 (pt) |
| AT (1) | ATE540039T1 (pt) |
| AU (1) | AU2009259121B2 (pt) |
| BR (1) | BRPI0915126B8 (pt) |
| CA (1) | CA2727669C (pt) |
| CL (1) | CL2010001429A1 (pt) |
| CO (1) | CO6280535A2 (pt) |
| CR (1) | CR11832A (pt) |
| CY (1) | CY1112610T1 (pt) |
| DK (1) | DK2297148T3 (pt) |
| DO (2) | DOP2010000380A (pt) |
| EA (1) | EA019074B1 (pt) |
| EC (1) | ECSP10010672A (pt) |
| ES (1) | ES2379685T3 (pt) |
| FR (1) | FR2932482B1 (pt) |
| HK (1) | HK1158631A1 (pt) |
| HR (1) | HRP20120290T1 (pt) |
| IL (1) | IL209902A (pt) |
| JO (1) | JO2774B1 (pt) |
| MA (1) | MA32474B1 (pt) |
| MX (1) | MX2010013695A (pt) |
| MY (1) | MY150988A (pt) |
| NI (1) | NI201000215A (pt) |
| NZ (1) | NZ589840A (pt) |
| PE (1) | PE20110154A1 (pt) |
| PL (1) | PL2297148T3 (pt) |
| PT (1) | PT2297148E (pt) |
| RS (1) | RS52262B (pt) |
| SI (1) | SI2297148T1 (pt) |
| SV (1) | SV2010003755A (pt) |
| TW (1) | TWI432433B (pt) |
| UA (1) | UA101979C2 (pt) |
| UY (1) | UY31893A (pt) |
| WO (1) | WO2009150388A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2931223B1 (fr) | 2008-05-16 | 2010-08-20 | Air Liquide | Dispositif distributeur de gaz sous pression, ensemble comprenant un tel dispositif et dispositif de commande, recipient pourvu d'un tel dispositif distributeur |
| FR2932481B1 (fr) * | 2008-06-13 | 2010-10-08 | Sanofi Aventis | Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique. |
| FR2953836B1 (fr) | 2009-12-14 | 2012-03-16 | Sanofi Aventis | Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75 |
| FR2953839A1 (fr) | 2009-12-14 | 2011-06-17 | Sanofi Aventis | Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75 |
| EP2606894A1 (en) * | 2011-12-20 | 2013-06-26 | Sanofi | Novel therapeutic use of p75 receptor antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3236243A1 (de) * | 1982-09-30 | 1984-04-05 | Merck Patent Gmbh, 6100 Darmstadt | Schwefelhaltige indolderivate |
| FR2744448B1 (fr) * | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
| US6613942B1 (en) * | 1997-07-01 | 2003-09-02 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| WO1999001423A1 (en) * | 1997-07-01 | 1999-01-14 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| AU4198400A (en) | 1999-04-06 | 2000-10-23 | Krenitsky Pharmaceuticals Inc. | Neurotrophic thio substituted pyrimidines |
| UA77526C2 (en) * | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
| FR2862967B1 (fr) * | 2003-12-01 | 2006-08-04 | Sanofi Synthelabo | Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique |
| FR2862968B1 (fr) | 2003-12-01 | 2006-08-04 | Sanofi Synthelabo | Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique |
| FR2932481B1 (fr) | 2008-06-13 | 2010-10-08 | Sanofi Aventis | Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique. |
-
2008
- 2008-06-13 FR FR0803299A patent/FR2932482B1/fr not_active Expired - Fee Related
-
2009
- 2009-06-04 JO JO2009204A patent/JO2774B1/en active
- 2009-06-11 TW TW098119564A patent/TWI432433B/zh active
- 2009-06-11 AR ARP090102110A patent/AR072103A1/es active IP Right Grant
- 2009-06-12 MX MX2010013695A patent/MX2010013695A/es active IP Right Grant
- 2009-06-12 PT PT09761939T patent/PT2297148E/pt unknown
- 2009-06-12 UA UAA201100370A patent/UA101979C2/ru unknown
- 2009-06-12 JP JP2011513038A patent/JP5476373B2/ja active Active
- 2009-06-12 DK DK09761939.9T patent/DK2297148T3/da active
- 2009-06-12 SI SI200930220T patent/SI2297148T1/sl unknown
- 2009-06-12 AU AU2009259121A patent/AU2009259121B2/en active Active
- 2009-06-12 ES ES09761939T patent/ES2379685T3/es active Active
- 2009-06-12 AT AT09761939T patent/ATE540039T1/de active
- 2009-06-12 EP EP09761939A patent/EP2297148B8/fr active Active
- 2009-06-12 WO PCT/FR2009/051118 patent/WO2009150388A1/fr active Application Filing
- 2009-06-12 KR KR1020117000792A patent/KR101642526B1/ko active IP Right Grant
- 2009-06-12 CA CA2727669A patent/CA2727669C/fr active Active
- 2009-06-12 UY UY0001031893A patent/UY31893A/es not_active Application Discontinuation
- 2009-06-12 CN CN200980131366.XA patent/CN102124006B/zh active Active
- 2009-06-12 PE PE2010001120A patent/PE20110154A1/es not_active Application Discontinuation
- 2009-06-12 RS RS20120137A patent/RS52262B/en unknown
- 2009-06-12 BR BRPI0915126A patent/BRPI0915126B8/pt active Search and Examination
- 2009-06-12 EA EA201170016A patent/EA019074B1/ru not_active IP Right Cessation
- 2009-06-12 PL PL09761939T patent/PL2297148T3/pl unknown
- 2009-06-12 MY MYPI20105850 patent/MY150988A/en unknown
- 2009-06-12 NZ NZ589840A patent/NZ589840A/xx not_active IP Right Cessation
-
2010
- 2010-12-08 DO DO2010000380A patent/DOP2010000380A/es unknown
- 2010-12-08 CR CR11832A patent/CR11832A/es unknown
- 2010-12-09 SV SV2010003755A patent/SV2010003755A/es unknown
- 2010-12-09 IL IL209902A patent/IL209902A/en active IP Right Grant
- 2010-12-10 EC EC2010010672A patent/ECSP10010672A/es unknown
- 2010-12-10 NI NI201000215A patent/NI201000215A/es unknown
- 2010-12-13 CO CO10156029A patent/CO6280535A2/es active IP Right Grant
- 2010-12-13 US US12/966,413 patent/US8193190B2/en active Active
- 2010-12-13 CL CL2010001429A patent/CL2010001429A1/es unknown
-
2011
- 2011-01-13 MA MA33517A patent/MA32474B1/fr unknown
- 2011-11-29 HK HK11112930.5A patent/HK1158631A1/xx not_active IP Right Cessation
-
2012
- 2012-04-02 HR HR20120290T patent/HRP20120290T1/hr unknown
- 2012-04-04 CY CY20121100339T patent/CY1112610T1/el unknown
- 2012-05-17 US US13/473,885 patent/US8519143B2/en active Active
-
2013
- 2013-06-04 DO DO2013000124A patent/DOP2013000124A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2170860I2 (lt) | Benzimidazolo dariniai | |
| DK2250161T3 (da) | Forbindelser med CRTH2-antagonistaktivitet | |
| BRPI1012679A2 (pt) | derivados de piperidina e piperazina como inibidores de autotaxina | |
| BRPI0811065A2 (pt) | Indazóis 5-heteroaril substituídos como inibidores de quinase | |
| BRPI0913322A2 (pt) | derivado de benzeno ou tiofeno e uso do mesmo como inibidor de vap-1 | |
| BRPI0906625A2 (pt) | Derivados de tio-2-amino-quinolina-6-substituída úteis como inibidores da beta-secretase (bace) | |
| BRPI0817644A2 (pt) | Derivados de piperidina e piperazina | |
| BRPI0907061A2 (pt) | Derivados de 2-aminoquinolina úteis como inibidores de beta-secretase (base) | |
| BRPI0812825A2 (pt) | Derivados ftalazinona como inibidores de parp-1 | |
| DK2310501T3 (da) | Nye regulatoriske elementer | |
| BRPI0915991A2 (pt) | derivados de sulfamida substituída | |
| BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
| BRPI0906352A2 (pt) | Derivado de tiazol e uso do mesmo como inibidores de vap-1 | |
| DK2318378T3 (da) | Quinazolin-derivater | |
| BRPI0906062A2 (pt) | Inibidores de sinalização de brassinosteróides | |
| ATE482613T1 (de) | Selbstreinigendes reihengerät | |
| BRPI0718436A2 (pt) | Novos derivados de benzamida como antagonistas da bradicina | |
| BRPI0914160A2 (pt) | aril cetona como mri | |
| JP2009543766A5 (ja) | ｍＰＧＥｓ−１阻害剤としての２−アリールインドール誘導体 | |
| ATE534634T1 (de) | 2-phenyl-4-cyclopropyl-pyrimidinderivate | |
| DE502007003530D1 (de) | Wirkwerkzeuganordnung und Wirkwerkzeug | |
| BRPI0913349A2 (pt) | derivados de ureia e sulfamida macrocíclicos como inibidores de tafia | |
| BRPI0915126A2 (pt) | derivados de (piperazinil em ponte) -1 alcanona e a respectiva utilização como inibidores de p75 | |
| BRPI0806542A2 (pt) | Derivados de sulfonamida como inibidores de quimase | |
| DE112009004836A5 (de) | Ecdyson-derivate und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/06/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |